Abstract
AbstractA mass Japanese encephalitis (JE) immunization campaign for children aged 9 months through 12 years was conducted in 2013 in Battambang province, western Cambodia. Vaccinators working at almost 2,000 immunization posts in approximately 800 villages provided vaccinations to almost 310,000 children using one dose of Chengdu Institute of Biological Products’ live, attenuated SA14-14-2 JE vaccine (CD-JEV), achieving a coverage rate of greater than 90%. Lessons learned, in general for mass vaccination campaigns and specifically for vaccination with CD-JEV, are described. These observations will be of benefit for public health officials and to help inform planning for future campaigns for JE or other vaccine-preventable diseases in Cambodia and elsewhere.
Funder
Bill and Melinda Gates Foundation
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference14 articles.
1. Hills SL, Van Cuong N, Touch S, et al. Disability from Japanese encephalitis in Cambodia and Viet Nam. J Trop Pediatr. 2011;57:241–4.
2. World Health Organization. Japanese encephalitis vaccines: WHO position paper - February 2015. Wkly Epidemiol Rec. 2015;90:69–87.
3. Campbell GL, Hills SL, Fischer M, et al. Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ. 2011;89(766–74):774A-774E.
4. Vannice KS, Hills SL, Schwartz LM, et al. The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control. NPJ Vaccines. 2021;6:82.
5. World Health Organization. Immunization coverage cluster survey – Reference manual. Report no: WHO/IVB/04.23. 2005. Geneva: World Health Organization. Available at: https://apps.who.int/iris/bitstream/handle/10665/69087/WHO_IVB_04.23.pdf;sequence=1
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献